doi: 10.7326/M16-2883.
Epub 2017 Jan 3.
Glycemic Therapy for Type 2 Diabetes: Choices Expand, Data Lag Behind
Affiliations
- PMID: 28055042
- DOI: 10.7326/M16-2883
Item in Clipboard
Glycemic Therapy for Type 2 Diabetes: Choices Expand, Data Lag Behind
Ann Intern Med.
.
No abstract available
Similar articles
-
[Guideline: type 2 diabetes mellitus therapy: metformin, a critical perspective].Acta Med Port. 2011 Mar-Apr;24(2):331-8. Epub 2011 May 20. Acta Med Port. 2011. PMID: 22011607 Portuguese.
-
[Guidelines for the management of diabetes mellitus type 2].Semergen. 2014 Sep;40 Suppl 4:11-8. doi: 10.1016/S1138-3593(14)74392-8. Semergen. 2014. PMID: 25595348 Spanish.
-
[40 years of Metformin in the treatment of diabetes mellitus].Internist (Berl). 1997 Jul;38(7 Suppl 40 Jahre):1-8. Internist (Berl). 1997. PMID: 9330653 German. No abstract available.
-
Therapeutic choices, and the nurse practitioner's role, in type 2 diabetes when metformin alone is no longer enough.J Am Acad Nurse Pract. 2012 Apr;24 Suppl 1:234-48. doi: 10.1111/j.1745-7599.2012.00720.x. J Am Acad Nurse Pract. 2012. PMID: 22564100 Review.
-
Present recommendations in type 2 diabetes treatment.Endocrinol Nutr. 2009 Dec;56 Suppl 4:46-9. Endocrinol Nutr. 2009. PMID: 20629232 Review. No abstract available.
Cited by
-
Mesenchymal Stem Cell-Based Therapy for Diabetes Mellitus: Enhancement Strategies and Future Perspectives.Stem Cell Rev Rep. 2021 Oct;17(5):1552-1569. doi: 10.1007/s12015-021-10139-5. Epub 2021 Mar 5. Stem Cell Rev Rep. 2021. PMID: 33675006 Review.
-
Stem cells as a potential therapy for diabetes mellitus: a call-to-action in Latin America.Diabetol Metab Syndr. 2019 Feb 18;11:20. doi: 10.1186/s13098-019-0415-0. eCollection 2019. Diabetol Metab Syndr. 2019. PMID: 30820250 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
